Cargando…
Impact of immune checkpoint inhibitors on atherosclerosis progression in patients with lung cancer
BACKGROUND: Patients with lung cancer face a heightened risk of atherosclerosis-related cardiovascular events. Despite the strong scientific rationale, there is currently a lack of clinical evidence examining the impact of immune checkpoint inhibitors (ICIs) on the advancement of atherosclerosis in...
Autores principales: | Drobni, Zsofia Dora, Gongora, Carlos, Taron, Jana, Suero-Abreu, Giselle A, Karady, Julia, Gilman, Hannah K, Supraja, Sama, Nikolaidou, Sofia, Leeper, Nicolas, Merkely, Béla, Maurovich-Horvat, Pal, Foldyna, Borek, Neilan, Tomas G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10347471/ https://www.ncbi.nlm.nih.gov/pubmed/37433718 http://dx.doi.org/10.1136/jitc-2023-007307 |
Ejemplares similares
-
Pericardial disease in patients treated with immune checkpoint inhibitors
por: Gong, Jingyi, et al.
Publicado: (2021) -
Radiomics versus Visual and Histogram-based Assessment to Identify Atheromatous Lesions at Coronary CT Angiography: An ex Vivo Study
por: Kolossváry, Márton, et al.
Publicado: (2019) -
The Prediction of Cardiac Events Using Contemporary Risk Prediction Models after Radiation Therapy for Head and Neck Cancer
por: Alvi, Raza M., et al.
Publicado: (2022) -
Heritability of Coronary Artery Disease: Insights From a Classical Twin Study
por: Drobni, Zsofia D., et al.
Publicado: (2022) -
Renin–angiotensin–aldosterone system inhibitors and survival in patients with hypertension treated with immune checkpoint inhibitors
por: Drobni, Zsofia D., et al.
Publicado: (2022)